Inflammatory Bowel Disease (IBD) Research Review, Issue 44

In this issue:

Does antibiotic exposure contribute to the development of IBD?
Childhood outcomes following in utero exposure to thiopurines or anti-TNF agents
Vedolizumab versus TNF-antagonist therapy for Crohn’s disease
Basal cell cancer recurrence in patients with IBD treated with immunosuppressive medications
Comparison of biologics in the first- and second-line setting for ulcerative colitis
Better clinical outcomes in Crohn’s disease are associated with complete mucosal healing
Prognostic potential of intestinal ultrasound in IBD
Increased discontinuation rates of anti-TNF therapy in elderly IBD patients
High rates of IBD relapse following vedolizumab discontinuation
Reduced risk of Crohn’s disease with a Mediterranean diet

Please login below to download this issue (PDF)

Subscribe